Using FISH to Diagnose Melanoma
Author Information
Author(s): Mathew W. Moore, Robert Gasparini
Primary Institution: NeoGenomics Laboratories
Hypothesis
Can FISH testing improve the diagnosis of challenging melanocytic lesions?
Conclusion
FISH testing is an effective diagnostic tool that can identify high-risk melanocytic lesions with genetic abnormalities.
Supporting Evidence
- The FISH assay identified genetic abnormalities in 83.8% of melanomas.
- Only 1.9% of benign nevi showed genetic abnormalities.
- The assay demonstrated a correlation between atypical nevi and genetic abnormalities.
Takeaway
This study shows that a special test called FISH can help doctors find out if certain skin spots are cancerous by looking for genetic changes.
Methodology
A four probe FISH assay was used to analyze 500 samples including nevi and melanoma specimens.
Potential Biases
Potential selection bias in sample collection from commercial laboratories.
Limitations
The study could not follow dysplastic nevi to confirm progression to melanoma due to standard excision practices.
Participant Demographics
Included 500 samples: 157 nevi, 176 dysplastic nevi, and 167 melanoma cases.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website